Podatki
-
Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year
Cullinan Therapeutics posts $0.73 per share loss in Q4 2025, matching year-ago results as the pre-revenue biotech maintains clinical development focus. The post Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year first appeared on Alphastreet.
AlphaStreet
2026-03-10, 15:04
-
BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Guides 2026 Revenue to $130M-$135M
BETA Technologies reported a Q4 loss of $1.71/share vs expected $0.47 loss, but guided 2026 revenue to $130M-$135M as certification milestones advance. The post BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Guides 2026 Revenue to $130M-$135M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:06
-
Septerna (SEPN) Reports Narrower Q4 Loss of $0.24/Share as Revenue Climbs to $24.1M
Septerna reports Q4 loss of $0.24/share, wider than expected, as revenue climbs to $24.1M from minimal levels earlier in fiscal 2025. The post Septerna (SEPN) Reports Narrower Q4 Loss of $0.24/Share as Revenue Climbs to $24.1M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:10
-
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate; Shares Surge 19%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate; shares jump 19% as clinical-stage biotech shows sequential improvement. The post Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate; Shares Surge 19% first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:20
-
Priority Technology (PRTH) reports Q4 Adjusted EPS of $0.11, Revenue Up 8.8%
Priority Technology Holdings posted Q4 adjusted EPS of $0.27, up 621% year-over-year, with revenue climbing 8.8% to $247.1 million. The post Priority Technology (PRTH) reports Q4 Adjusted EPS of $0.11, Revenue Up 8.8% first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:25
-
SuRo Capital Corp (SSSS) Reports Wider Loss Q4 Estimates by 10.0%
**SuRo Capital Corp Reports Wider-Than-Expected Q4 Loss** The post SuRo Capital Corp (SSSS) Reports Wider Loss Q4 Estimates by 10.0% first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:27
-
Opus Genetics (IRD) Reports $0.80 Q4 Loss Despite 230% Revenue Surge to $14.2M
Opus Genetics posts $0.80 Q4 loss as revenue surges 230% year-over-year to $14.2M on collaboration activity. The post Opus Genetics (IRD) Reports $0.80 Q4 Loss Despite 230% Revenue Surge to $14.2M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:32
-
Prelude Therapeutics (PRLD) Q4 Loss Widens 616.7% to $1.29/Share as Revenue Climbs to $12.1M
Prelude Therapeutics reports Q4 loss of $1.29/share, 616.7% wider than expected, despite revenue jumping to $12.1M from $6.5M sequentially. The post Prelude Therapeutics (PRLD) Q4 Loss Widens 616.7% to $1.29/Share as Revenue Climbs to $12.1M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 14:35
-
Yalla Group (YALA) Q4 Earnings Flat at $0.21 EPS, $83.9M Revenue Signals Growth Stall
Yalla Group's Q4 adjusted EPS of $0.21 and revenue of $83.9M matched the prior quarter exactly, signaling a growth plateau. The post Yalla Group (YALA) Q4 Earnings Flat at $0.21 EPS, $83.9M Revenue Signals Growth Stall first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:41
-
Yalla Group (YALA) Reports Q4 EPS of $0.20 as Revenue Stalls at $83.9M
Yalla Group reports Q4 adjusted EPS of $0.21 on flat sequential revenue of $83.9M, maintaining profitability but showing zero growth. The post Yalla Group (YALA) Reports Q4 EPS of $0.20 as Revenue Stalls at $83.9M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:43
-
FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate, Revenue Misses by 29.5%
FuelCell Energy narrows Q1 loss to $0.52/share vs $0.68 estimate, but revenue of $30.5M misses $43.3M consensus by 29.5% on module timing. The post FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate, Revenue Misses by 29.5% first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:43
-
BETA Technologies (BETA) Reports Wider Q4 Loss But Forecasts Triple-Digit Revenue Growth for 2026
BETA Technologies reported Q4 loss of $1.71/share vs expected $0.47 loss; revenue $32.1M; guides 2026 revenue $130M-$135M, up 265% year-over-year. The post BETA Technologies (BETA) Reports Wider Q4 Loss But Forecasts Triple-Digit Revenue Growth for 2026 first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:59
-
Yext (YEXT) Q4 Earnings: $0.15 EPS as Revenue Flatlines at $112M
Yext reports Q4 adjusted EPS of $0.15, matching prior quarter, as revenue stalls at $112M year-over-year. The post Yext (YEXT) Q4 Earnings: $0.15 EPS as Revenue Flatlines at $112M first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:31
-
FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate; Revenue Misses by 30%
FuelCell Energy narrows Q1 loss to $0.52/share vs $0.68 estimate, but revenue of $30.5M misses $43.3M consensus by 30% on timing delays. The post FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate; Revenue Misses by 30% first appeared on Alphastreet.
AlphaStreet
2026-03-10, 13:33
-
Legend Biotech Q4 2025 Earnings Results
Legend Biotech (NASDAQ: LEGN) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting continued... The post Legend Biotech Q4 2025 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:48
-
ABM Industries Q1 FY26 Earnings Results
ABM Industries (NYSE: ABM) reported financial results for the first quarter of fiscal 2026, delivering solid revenue growth driven by... The post ABM Industries Q1 FY26 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:56
-
Unusual Machines Q4 FY25 Earnings Results
Revenue Performance Unusual Machines reported robust top-line expansion for the fourth quarter and full year ended December 31, 2025. Full-year... The post Unusual Machines Q4 FY25 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:07
-
ACCO Brands Q4 FY25 Earnings Results
Revenue Performance ACCO Brands Corporation reported full-year 2025 net sales of $1.525 billion, representing an 8.5 percent decline from the... The post ACCO Brands Q4 FY25 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:14
-
U.S. Regulators Turn Up the Heat on Big Tech Acquisitions
TL;DR: Washington is tightening the screws on tech M&A, and the message from regulators is clear: the era of Big... The post U.S. Regulators Turn Up the Heat on Big Tech Acquisitions first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:16
-
Sharplink Q4 FY25 Earnings Results
Revenue Growth and Net Income Metrics Sharplink posted substantial top-line expansion for the full year ended December 31, 2025, recording... The post Sharplink Q4 FY25 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:21
-
ARS Pharmaceuticals Q4 FY25 Earnings Results
Revenue Performance ARS Pharmaceuticals recorded total revenue of $28.1 million for the fourth quarter of 2025, driven largely by $20.3... The post ARS Pharmaceuticals Q4 FY25 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:27
-
Kohl’s Corporation Q4 FY25 Earnings Results
Revenue Performance Kohl’s Corporation reported a decline in top-line results for both the fourth quarter and the full fiscal year... The post Kohl’s Corporation Q4 FY25 Earnings Results first appeared on Alphastreet.
AlphaStreet
2026-03-10, 12:35
-
Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss
Repay posts $0.24 adjusted EPS on flat $77.7M revenue, with GAAP loss of $6.6M highlighting profitability adjustments ahead of tonight's call. The post Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss first appeared on test.
AlphaStreet
2026-03-09, 21:11
-
RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares
CEO Carsten Brunn sold 23,766 shares at $6.82 per share, totaling $162,077, while retaining 323,530 shares. The post RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares first appeared on test.
AlphaStreet
2026-03-09, 21:12
-
Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth
Korn Ferry posted Q3 adjusted EPS of $1.28, down 7.6% year-over-year, as revenue of $725M rose 7.2% but slipped sequentially. The post Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth first appeared on test.
AlphaStreet
2026-03-09, 21:14